MyMeds&Me Announces Collaboration with Oracle Health Sciences
MyMeds&Me, a provider of SaaS, web-based adverse event and product quality capture solutions for life sciences, announced its collaboration with Oracle Health Sciences to provide the Reportum® solution to Oracle Argus safety customers.
MyMeds&Me, a provider of SaaS, web-based adverse event and product quality capture solutions for life sciences, announced its collaboration with Oracle Health Sciences to provide the Reportum® solution to Oracle Argus safety customers. This collaboration allows access to the innovative Reportum® solution providing a standardized method of capturing complete Adverse Event data at source, from all reporter types. The Reportum® solution provides web-based safety data capture at initial reporter interaction and supports direct reporting by consumers, streamlining a traditionally paper-based activity that can generate duplicate data entry.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Oveporexton Shows Superior Efficacy in Phase II Narcolepsy Type 1 Trial Without Hepatotoxicity
May 16th 2025In the TAK-861-2001 Phase IIb study, oveporexton significantly improved wakefulness, daytime sleepiness, and cataplexy frequency in patients with narcolepsy type 1, outperforming current therapies and avoiding liver toxicity seen with earlier OX2R agonists, according to results published in The New England Journal of Medicine.
